Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10259887 Heterodimeric antibodies that bind CD3 and tumor antigens

Patent 10259887 was granted and assigned to Xencor on April, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Xencor

Current Assignee

Xencor

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

102598870

Patent Inventor Names

Umesh Muchhal0

Gregory Moore0

John Desjarlais0

Matthew J. Bernett0

Rumana Rashid0

Seung Chu0

Sung-Hyung Lee0

Date of Patent

April 16, 2019

Patent Application Number

151413500

Date Filed

April 28, 2016

Patent Citations Received

‌

US Patent 12129309 Heterodimeric antibodies that bind CD3 and CD38

‌

US Patent 10793632 Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors

‌

US Patent 10858417 Heterodimeric proteins

‌

US Patent 11919956 Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3

Patent Primary Examiner

‌

Sean D Aeder

Patent abstract

The present invention is directed to novel heterodimeric antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10259887 Heterodimeric antibodies that bind CD3 and tumor antigens

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API